Donor Blood Procurement and Utilisation at the University of Benin Teaching Hospital, Benin City

ME Enosolease, CO Imarengiaye OA Awodu

Abstract

Banked blood is a limited resource in Nigeria. We sought to evaluate factors that may further limit the effective utilisation of donor blood in a tertiary hospital in Benin City. The records of the blood transfusion unit of the hospital were studied to identify the methods of blood procurement and utilisation from January 1, 2000 to December 31, 2002. A total of 11,021 units of blood were received in the blood transfusion unit within this period out of which 1491 (13.5%) donor blood samples were found unfit for transfusion and, hence, discarded. Commercial blood donation accounted for 95.3%, compared to 4.7% from replacement and volunteer donors. Commercial blood donation was a major risk factor for likely disposal of donor blood (x2 = 74.3, p < 0.0001, OR = 21.1, 95% CI = 7.8-56.7). Expired units of blood with low PCV were discarded for lack of infrastructure to fractionate and store them. Over N 0.8million (US$6000.00) is wasted annually on discarded units of donor blood mainly from commercial donors. A policy on blood procurement to include subgroup selection of donors and improved funding of blood banking services may enhance efficient and effective utilisation of donor blood. (Afr J Reprod Health 2004; 8[2]: 59-63)

 

Keywords: Donor blood, precurement, transfusion-related viral infection

Full Text:

DOC

References

Emeribe AO, Ejele AO, Atai EE and Usanga EA. Blood donation and patterns of use in south-eastern Nigeria. Transfussion1993; 33: 330-332.

Kasili EG. Blood transfusion services in a developing country: the concept and problems of organization (editorial). E Afr Med J 1981; 58: 81-83.

Sarkodie F, Adarkwa M, Adu-Sarkodie Y, Candotti D, Acheampong JW and Allain JP. Screening for viral markers in volunteer and replacement blood donors in West Africa. Vox Sang 2001; 80: 142-147.

Mwangi JW. Viral markers in a blood donor population. E Afr Med J 1999; 76: 35-37.

Matee MI, Lyamuya EF, Mbena EC, Magessa PM, Sufi J, Marwa GJ Mwasulama OJ and Mbawana. E Afr Med J 1999; 76: 167-171.

Kinde-Gazard, Oke J, Gnahoui I, and Massougbodje A. The risk of malaria transmission of infectious agents by blood transfusion at Cotonou, Benin. Sante 2000; 6: 389-392.

Moore A, Herrera G, Nyamongo J, Lackritz E, Granade T, Nahlen B, Oloo A, Opondo G, Muga R and Janssen R. Estimated risk of HIV transmission by blood transfusion in Kenya. Lancet 2001; 358: 657-660.

Candotti D, Sarkodie F and Allain JP. Residual risk of transfusion in Ghana. Br J Haematol 2001; 113: 37-39.

Reiche EM, Vogler IH, Morimoto HK, Matsuo T, Yuahasi KK, Cancian SK and Koguichi RS. Evaluation of surrogate markers for human immunodeficiency virus infection among blood donors at blood bank of Hospital Univeristarion Regional Norte do Parana, Londrina, PR, Brazil. Rev Inst Med Trop Sao Paulo. 2003; 45: 23-7.

Sentjens RE, Sisay Y, Vrielink H, Kebede D, Ader HJ, Leckie G and Resink HW. Prevalence of and risk factors for HIV infection in blood donors and various population subgroups in Ethiopia. Epidemiol Infect 2002; 128: 221-228.

vanHoogstraten MJ, Consten EC, Henny CP, Heij HA and van Lanschot JJ. Are there simple measures to reduce the risk of HIV infection through blood transfusion in a Zambian district hospital.Trop Med Int Health 2000; 5: 668-673.

Hensher M and Jefferys E. Financing blood transfusion services In sub-Saharan Africa: a role user fees. Health Policy Plan 2000; 15: 287-275.

Refbacks

  • There are currently no refbacks.